BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12820467)

  • 1. Clinical relevance of meta-analysis of survival benefit when deciding treatment of adjuvant chemotherapy in gastric cancer.
    Kim R; Toge T
    Anticancer Res; 2003; 23(2C):1843-6. PubMed ID: 12820467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant chemotherapy for gastric cancer in Japan: global and Japanese perspectives.
    Sakamoto J; Morita S; Kodera Y; Rahman M; Nakao A
    Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S25-31. PubMed ID: 15309511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status and future perspectives of post-operative adjuvant therapy for gastric carcinoma.
    Kim R; Yoshida K; Toge T
    Anticancer Res; 2002; 22(1A):283-9. PubMed ID: 12017304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of current adjuvant and neoadjuvant therapeutic concepts in gastric cancer?].
    Kretzschmar A; Schlag PM
    Zentralbl Chir; 2006 Apr; 131(2):121-5. PubMed ID: 16612778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current status and future perspectives on chemotherapy in patients with gastric cancer: can the clinical data from Japan lead to a standard international therapy?].
    Kim R; Yoshida K; Toge T
    Nihon Geka Gakkai Zasshi; 2001 Oct; 102(10):770-7. PubMed ID: 11681004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progress in postoperative adjuvant chemotherapy in gastric cancer].
    Nakajima T; Ohta K; Ohyama S; Yamaguchi T
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2481-7. PubMed ID: 12506470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative adjuvant chemotherapy of gastric cancer: scrutiny into the clinical evidence based on quality assessment of medical literature of randomized controlled trials.
    Jeung HC; Rha SY; Shin SJ; Ahn JB; Roh JK; Park CH; Noh SH; Chung HC
    Cancer Chemother Pharmacol; 2009 Apr; 63(5):919-27. PubMed ID: 18712389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer.
    Sun P; Xiang JB; Chen ZY
    Br J Surg; 2009 Jan; 96(1):26-33. PubMed ID: 19016271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of adjuvant therapy for resected gastric cancer: differences in Japan and the United States.
    Ohtsu A; Sasako M
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S101-4. PubMed ID: 16399444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant therapy in gastric cancer.
    Lim L; Michael M; Mann GB; Leong T
    J Clin Oncol; 2005 Sep; 23(25):6220-32. PubMed ID: 16135489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of intensive adjuvant chemotherapy in gastric cancer using life expectancy compared with log-rank test as a measure of survival benefit.
    Nishikawa T; Maetani S
    Ann Surg Oncol; 2007 Feb; 14(2):348-54. PubMed ID: 17091331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gastric cancer].
    Kinoshita T; Konishi M; Nakagohri T; Takahashi S; Gotouda N
    Gan To Kagaku Ryoho; 2006 Mar; 33(3):313-7. PubMed ID: 16531710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in our understanding of postoperative adjuvant chemotherapy in resectable non-small-cell lung cancer.
    Hotta K; Matsuo K; Kiura K; Ueoka H; Tanimoto M
    Curr Opin Oncol; 2006 Mar; 18(2):144-50. PubMed ID: 16462183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selecting a specific pre- or postoperative adjuvant therapy for individual patients with operable gastric cancer.
    Briasoulis E; Liakakos T; Dova L; Fatouros M; Tsekeris P; Roukos DH; Kappas AM
    Expert Rev Anticancer Ther; 2006 Jun; 6(6):931-9. PubMed ID: 16761937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adjuvant chemotherapy using S-1 for curatively resected gastric cancer-the nationwide clinical trial].
    Sasako M; Saka M; Fukagawa T; Katai H; Sano T
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():110-6. PubMed ID: 16897984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnitude of benefit of adjuvant chemotherapy for non-small cell lung cancer: meta-analysis of randomized clinical trials.
    Bria E; Gralla RJ; Raftopoulos H; Cuppone F; Milella M; Sperduti I; Carlini P; Terzoli E; Cognetti F; Giannarelli D
    Lung Cancer; 2009 Jan; 63(1):50-7. PubMed ID: 18565615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of postoperative adjuvant chemotherapy following curative resection for gastric cancer: a meta-analysis.
    Zhao SL; Fang JY
    Cancer Invest; 2008; 26(3):317-25. PubMed ID: 18317973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.
    Benson AB; Schrag D; Somerfield MR; Cohen AM; Figueredo AT; Flynn PJ; Krzyzanowska MK; Maroun J; McAllister P; Van Cutsem E; Brouwers M; Charette M; Haller DG
    J Clin Oncol; 2004 Aug; 22(16):3408-19. PubMed ID: 15199089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current status of adjuvant chemotherapy of gastric cancer].
    Nakajima T; Nishi M
    Gan No Rinsho; 1986 Aug; 32(10):1219-22. PubMed ID: 3537362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy for non-small cell lung cancer: ready for clinical practice?
    Tiseo M; Franciosi V; Grossi F; Ardizzoni A
    Eur J Cancer; 2006 Jan; 42(1):8-16. PubMed ID: 16293409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.